Novel polymorphisms in CYP4A22 associated with susceptibility to coronary heart disease.

Authors:
Huang K; Ma T; Li Q; Zhong Z; Zhou Y and 5 more

Journal:
BMC Med Genomics

Publication Year: 2024

DOI:
10.1186/s12920-024-01833-7

PMCID:
PMC10913669

PMID:
38438909

Journal Information

Journal Title: BMC Med Genomics

Detailed journal information not available.

Publication Details

Subject Category: Genetics & Heredity

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Evidence found in paper:

"data availability the datasets generated and/or analyzed during the current study are available in the [zenodo] repository 10 5281/zenodo 7543554. data availability the datasets generated and/or analyzed during the current study are available in the [zenodo"

Code Sharing
Evidence found in paper:

"Declarations Ethics approval and consent to participateThis study was approved by the ethics committee of Central South University Xiangya School of Medicine Affiliated Haikou Hospital (2020-(Ethics Review)-048). Before blood collection, we fully informed all subjects of the purpose and significance of this study and obtained their informed consent. Consent for publicationNot Applicable. Competing interestsThe authors declare that they have no conflict of interest. Competing interests The authors declare that they have no conflict of interest."

Evidence found in paper:

"Funding This study was Supported by the specific research fund of The Innovation Platform for Academicians of Hainan Province (No. YSPTZX202032: Dynamic monitoring and genetic correlation of blood biochemical indexes related to cardiovascular and cerebrovascular diseases in ‘migratory bird population’ in Hainan)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025